Capucine Baldini

France

Biographical Info
Drug Development Department (DITEP); Gustave Roussy; Villejuif; France Dr Capucine Baldini is a medical oncologist working at the Drug Development Department (DITEP); Gustave Roussy; Villejuif; France. She is involved in early phase trials with a special interest in geriatric oncology; gastro-intestinal cancers; genitourinary cancers; and central nervous system tumours. Dr Baldini received her medical degree from Lille II University in 2014 and got a MSc from PARIS XI University in 2013. She was an assistant Professor at Lille University Hospital with a specialisation in geriatric oncology and at Gustave Roussy in early phase trials at DITEP. She is a member of ESMO; ASCO; AACR; SIOG; SoFOG and involved in young SIOG and SoFOG interest group leadership. She is working on early phase trials and immunotherapy in older patients. She is a subinvestigator of more than 80 clinical trials (phase I trials) and a (co)author of several publications in peer reviewed journals. Research axes: early clinical trials; geriatric oncology; genitourinary cancers (prostate cancer; bladder cancer); glioma. Dr Capucine Baldini is a medical oncologist working at the Drug Development Department (DITEP); Gustave Roussy; Villejuif; France. She is involved in early phase trials with a special interest in geriatric oncology; gastro-intestinal cancers; genitourinary cancers; and central nervous system tumours. Dr Baldini received her medical degree from Lille II University in 2014 and got a MSc from PARIS XI University in 2013. She was an assistant Professor at Lille University Hospital with a specialisation in geriatric oncology and at Gustave Roussy in early phase trials at DITEP. She is a member of ESMO; ASCO; AACR; SIOG; SoFOG and involved in young SIOG and SoFOG interest group leadership. She is working on early phase trials and immunotherapy in older patients. She is a subinvestigator of more than 80 clinical trials (phase I trials) and a (co)author of several publications in peer reviewed journals. Research axes: early clinical trials; geriatric oncology; genitourinary cancers (prostate cancer; bladder cancer); glioma.